Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

Form 8.3 - HAT LN

15 May 2025 15:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

H&T Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

14 May 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

 

5p ordinary

 

 

 

Interests

 

Short positions

 

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

702,627

 

1.60%

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

 

TOTAL:

 

702,627

 

1.60%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/sale

 

 

Number of securities

 

Price per unit

5p ordinary

 

Purchase

 

75,000

 

641.6667p

5p ordinary

 

Purchase

 

127,627

 

641p

5p ordinary

 

Purchase

 

100,000

 

641p

5p ordinary

 

Purchase

 

100,000

 

641p

5p ordinary

 

Purchase

 

100,000

 

643.5p

5p ordinary

 

Purchase

 

200,000

 

642p

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

 

No

Date of disclosure:

 

15 May 2025

Contact name:

 

James Evans

Telephone number:

 

+44 20 3161 0743

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250515241464/en/

Copyright Business Wire 2025

Date   Source Headline
29th Sep 20224:43 pmRNSProposed Capital Raise of up to £16.9m
9th Sep 20227:00 amRNSAppointment of Non-Executive Director
18th Aug 202210:33 amRNSHolding(s) in Company
17th Aug 20225:20 pmRNSStandard form for notification of major holdings
9th Aug 20227:00 amRNSInterim Results
8th Jul 20229:08 amRNSHolding(s) in Company
6th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:01 amRNSAcquisition of Swiss Time Services Limited
4th Jul 20227:00 amRNSTrading Update and Notice of Results
29th Jun 20226:18 pmRNSHolding(s) in Company
30th May 20227:00 amRNSPerformance Share Plan ("PSP") 2022
13th May 20227:00 amRNSResult of AGM
12th May 20227:00 amRNSTrading Update
3rd May 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20223:22 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSAppointment of non-executive director
4th Apr 20227:00 amRNSUpdate on regulatory review into HCST lending
25th Mar 20221:49 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Jan 20227:00 amRNSTrading Update and Notice of Results
17th Jan 20227:00 amRNSChange of Nominated Adviser and Broker
20th Dec 20217:00 amRNSAnnouncement – Rule 17 Schedule 2(g) Updated
24th Nov 20219:52 amRNSDirector appointed
19th Nov 202112:08 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotification of major holdings
1st Nov 202110:22 amRNSH&T CFO appointment update
5th Oct 20212:30 pmRNSNotification of major holdings
10th Aug 20217:00 amRNSCorrection to Ex-Dividend and Record Date
9th Aug 20217:00 amRNSChief Finance Officer Appointment
9th Aug 20217:00 amRNSUnaudited Interim Results
21st Jul 20217:00 amRNSNotice of Interim Results
5th Jul 202111:56 amRNSPDMR Dealing
20th May 20213:00 pmRNSResult of Annual General Meeting
30th Apr 20217:00 amRNSBoard Changes - Chief Financial Officer
26th Apr 20217:00 amRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20217:00 amRNSPreliminary results for the year ended 31 Dec 2020
22nd Feb 20217:00 amRNSNotification of major holdings
25th Jan 20217:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
20th Nov 20207:00 amRNSDirector Dealings
9th Nov 20205:22 pmRNSChange of Auditor
5th Nov 202011:00 amRNSBusiness update
2nd Nov 20207:00 amRNSChange of Auditor
29th Oct 20207:00 amRNSH&T CEO appointment
26th Oct 20207:00 amRNSDirectorate Change
13th Oct 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20207:00 amRNSDirector Dealings
25th Aug 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20208:37 amRNSTR-1: Notification of major holdings
13th Aug 20201:50 pmRNSAIM Rule 17 disclosure
11th Aug 20202:50 pmRNSInterim Results – Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.